Cargando…
Erratum: SC83288 is a clinical development candidate for the treatment of severe malaria
Autores principales: | Pegoraro, Stefano, Duffey, Maëlle, Otto, Thomas D., Wang, Yulin, Rösemann, Roman, Baumgartner, Roland, Fehler, Stefanie K., Lucantoni, Leonardo, Avery, Vicky M., Moreno-Sabater, Alicia, Mazier, Dominique, Vial, Henri J., Strobl, Stefan, Sanchez, Cecilia P., Lanzer, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5384206/ https://www.ncbi.nlm.nih.gov/pubmed/28383016 http://dx.doi.org/10.1038/ncomms15273 |
Ejemplares similares
-
SC83288 is a clinical development candidate for the treatment of severe malaria
por: Pegoraro, Stefano, et al.
Publicado: (2017) -
Profiling of the anti-malarial drug candidate SC83288 against artemisinins in Plasmodium falciparum
por: Duffey, Maëlle, et al.
Publicado: (2018) -
Erratum
por: Hughes, Avery, et al.
Publicado: (2020) -
Erratum to: Structural characteristics of ScBx genes controlling the biosynthesis of hydroxamic acids in rye (Secale cereale L.)
por: Bakera, Beata, et al.
Publicado: (2016) -
Erratum to “Network Analysis of Language Disorganization in Patients with Schizophrenia” by Park SC, et al. (Yonsei Med J 2020; 61(8): 726-730.)
Publicado: (2020)